Biomarkers as Predictors for Conversion from Mild Cognitive Impairment to Alzheimer-Type Dementia: Implications for Trial Design

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)881-891
JournalJournal of Alzheimer's Disease
Volume20
Issue number3
DOIs
Publication statusPublished - 2010

Keywords

  • Alzheimer's disease
  • biomarkers
  • blood
  • cerebrospinal fluid
  • cost-benefit
  • decision analysis
  • mild cognitive impairment

Cite this